{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:23:54Z","timestamp":1790277834509,"version":"4.1.0"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jaut.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T17:31:12Z","timestamp":1555349472000},"page":"35-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["The neurological syndromes associated with glutamic acid decarboxylase antibodies"],"prefix":"10.1016","volume":"101","author":[{"given":"Jos\u00e9 Fidel","family":"Baizabal-Carvallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.04.007_bib1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199005313222202","article-title":"Autoantibodies to GABAergic neurons and pancreatic beta cells in stiff-man syndrome","volume":"322","author":"Solimena","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2011.05.005","article-title":"Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies","volume":"37","author":"Ali","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.04.007_bib3","first-page":"421","article-title":"Progressive fluctuating muscular rigidity and spasm (stiff-man syndrome): report of a case and some observations in 13 other cases","volume":"31","author":"Moersch","year":"1956","journal-title":"Proc. Staff Meet. Mayo Clin."},{"key":"10.1016\/j.jaut.2019.04.007_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","article-title":"Stiff person syndrome: advances in pathogenesis and therapeutic interventions","volume":"11","author":"Dalakas","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamaneurol.2013.4442","article-title":"Childhood onset of stiff-man syndrome","volume":"70","author":"Clardy","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/mds.870060104","article-title":"Stiff-person syndrome: an autoimmune disease","volume":"6","author":"Blum","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2014-309201","article-title":"Stiff-person syndrome: insights into a complex autoimmune disorder","volume":"86","author":"Baizabal-Carvallo","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-018-1232-z","article-title":"Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder","volume":"19","author":"Rakocevic","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00315688","article-title":"Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome","volume":"238","author":"Mitsumoto","year":"1991","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00936885","article-title":"Stiff man syndrome: neurophysiological findings in eight patients","volume":"242","author":"Meinck","year":"1995","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mds.10451","article-title":"Head retraction reflex in stiff-man syndrome and related disorders","volume":"18","author":"Berger","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/jnnp.74.4.462","article-title":"Specific phobia is a frequent non-motor feature in stiff man syndrome","volume":"74","author":"Henningsen","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib14","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/01.WNL.0000163984.71993.FE","article-title":"A neuropsychological assessment of phobias in patients with stiff person syndrome","volume":"64","author":"Ameli","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.65.5.633","article-title":"Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity","volume":"65","author":"Barker","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00415-003-1002-7","article-title":"The stiff limb syndrome--a new case and a literature review","volume":"250","author":"Bartsch","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/B:NEON.0000003754.34527.f2","article-title":"Anti-GAD antibody positive stiff-limb syndrome in multiple myeloma","volume":"65","author":"Schiff","year":"2003","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.jaut.2019.04.007_bib18","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1526-4637.2009.00578.x","article-title":"Stiff limb syndrome: end of spectrum or a separate entity?","volume":"10","author":"Misra","year":"2009","journal-title":"Pain Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/jnnp.43.12.1125","article-title":"A patient with reflex myoclonus and muscle rigidity: \"jerking stiff-man syndrome","volume":"43","author":"Leigh","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/jnnp.45.12.1159","article-title":"Jerking stiff-man syndrome","volume":"45","author":"Alberca","year":"1982","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","article-title":"Clinical and immunologic investigations in patients with stiff-person spectrum disorder","volume":"73","author":"Martinez-Hernandez","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib23","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mds.10235","article-title":"Quality of life in stiff-person syndrome","volume":"17","author":"Gerschlager","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004010050956","article-title":"Large motor neuron involvement in Stiff-man syndrome: a qualitative and quantitative study","volume":"97","author":"Ishizawa","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jaut.2019.04.007_bib25","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/mds.23784","article-title":"Pathological findings in a case of stiff person syndrome with anti-GAD antibodies","volume":"26","author":"Witherick","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.19.4.268","article-title":"Subacute myoclonic spinal neuronitis","volume":"19","author":"Campbell","year":"1956","journal-title":"J. Neurol. Neurosug. Psychiatry."},{"key":"10.1016\/j.jaut.2019.04.007_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/99.1.27","article-title":"Progressive encephalomyelitis with rigidity","volume":"99","author":"Whiteley","year":"1976","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib28","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib29","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/jnnp.2010.229104","article-title":"Antiglycine-receptor encephalomyelitis with rigidity","volume":"82","author":"Mas","year":"2011","journal-title":"J. Neurol. Neurosug. Psychiatry."},{"key":"10.1016\/j.jaut.2019.04.007_bib31","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1007\/s00415-011-6078-x","article-title":"A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings","volume":"258","author":"Piotrowicz","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","article-title":"Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype","volume":"70","author":"McKeon","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib33","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1212\/01.wnl.0000436617.40779.65","article-title":"Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders","volume":"81","author":"Alexopoulos","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib34","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1212\/NXI.0000000000000438","article-title":"Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders","volume":"5","author":"Hinson","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jaut.2019.04.007_bib35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/WNL.0b013e318227b176","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies","volume":"77","author":"Turner","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jnnp.42.9.773","article-title":"Spinal internuncial neurones in progressive encephalomyelitis with rigidity","volume":"42","author":"Howell","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archneur.1995.00540290050017","article-title":"Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements","volume":"52","author":"Honnorat","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00702-017-1754-3","article-title":"Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review","volume":"124","author":"Baizabal-Carvallo","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jaut.2019.04.007_bib40","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib41","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jnnp.73.3.345","article-title":"Acute attacks and brain stem signs in a patient with glutamic acid decarboxylase autoantibodies","volume":"73","author":"Matsumoto","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy","volume":"71","author":"Ari\u00f1o","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clineuro.2006.01.009","article-title":"Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease","volume":"109","author":"Chang","year":"2007","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jaut.2019.04.007_bib45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1590\/S0004-282X2011000700030","article-title":"Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy","volume":"69","author":"Pedroso","year":"2011","journal-title":"Arq Neuropsiquiatr."},{"key":"10.1016\/j.jaut.2019.04.007_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jnnp.2006.091116","article-title":"Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia","volume":"78","author":"Ishida","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2009.12.006","article-title":"Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies","volume":"290","author":"Piccolo","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0404.2010.01356.x","article-title":"GAD antibody-associated neurological illness and its relationship to gluten sensitivity","volume":"123","author":"Hadjivassiliou","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jaut.2019.04.007_bib49","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib51","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib52","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib53","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1001\/archneurol.2012.234","article-title":"Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia","volume":"69","author":"Mirabelli-Badenier","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib54","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejpn.2018.01.004","article-title":"Severe dysautonomia as a main feature of anti-GAD encephalitis: report of a paediatric case and literature review","volume":"22","author":"Ben Achour","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib55","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib56","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jns.2013.08.016","article-title":"Histopathological evidence that hippocampal atrophy following status epilepticus is a result of neuronal necrosis","volume":"334","author":"Kumar","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1684\/epd.2013.0607","article-title":"Acute amnesia and seizures in a young female","volume":"15","author":"Garc\u00eda Garc\u00eda","year":"2013","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13760-018-0880-5","article-title":"Autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: a case series","volume":"118","author":"Incecik","year":"2018","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jaut.2019.04.007_bib59","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pediatrneurol.2012.06.013","article-title":"Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus","volume":"47","author":"Lin","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib60","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1684\/epd.2013.0596","article-title":"Opercular myoclonic-anarthric status epilepticus due to glutamic acid decarboxylase antibody-associated encephalitis","volume":"15","author":"Monnerat","year":"2013","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib61","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2010.06.002","article-title":"Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report","volume":"19","author":"Cianci","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.jaut.2019.04.007_bib62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1684\/epd.2014.0666","article-title":"PET-positive extralimbic presentation of anti-glutamic acid decarboxylase antibody-associated encephalitis","volume":"16","author":"Kojima","year":"2014","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.yebeh.2011.03.038","article-title":"Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: an underdiagnosed entity?","volume":"21","author":"Najjar","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jaut.2019.04.007_bib64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1684\/epd.2015.0734","article-title":"Autoimmune encephalitis and anti-GAD\/GABA-A receptor antibodies","volume":"17","author":"Simabukuro","year":"2015","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib65","first-page":"179","article-title":"Long-term effect of rituximab in a case with late-onset Rasmussen's encephalitis with anti-ganglioside IgGQ1b and anti-GAD antibodies positivity. Case Report","volume":"37","author":"Timarova","year":"2016","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.jaut.2019.04.007_bib66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1695-4033(03)78746-3","article-title":"Rasmussen's syndrome, an autoimmune disease","volume":"59","author":"Carrillo Herranz","year":"2003","journal-title":"An. Pediatr."},{"key":"10.1016\/j.jaut.2019.04.007_bib67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(05)79192-3","article-title":"Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies","volume":"352","author":"Giometto","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.04.007_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-1211(00)00180-7","article-title":"Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study","volume":"42","author":"Kwan","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jaut.2019.04.007_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2018.09.009","article-title":"The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients","volume":"63","author":"Elisak","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.jaut.2019.04.007_bib70","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fneur.2018.00579","article-title":"Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs","volume":"9","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib71","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1542\/peds.109.3.e50","article-title":"Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies","volume":"109","author":"Olson","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaut.2019.04.007_bib72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/1550059412459330","article-title":"Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody","volume":"44","author":"Cikrik\u00e7ili","year":"2013","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.jaut.2019.04.007_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1684\/epd.2016.0797","article-title":"Refractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes","volume":"18","author":"Khawaja","year":"2016","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2018.06.013","article-title":"Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression","volume":"323","author":"Triplett","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.04.010","article-title":"Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients","volume":"211","author":"Errichiello","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib77","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1468-1331.2011.03609.x","article-title":"Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies","volume":"19","author":"Falip","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib78","first-page":"13","article-title":"Epilepsy and autoimmunity in pediatric patients","volume":"46","author":"Bekta\u015f","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jaut.2019.04.007_bib79","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.seizure.2014.04.009","article-title":"Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications","volume":"23","author":"Lilleker","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.jaut.2019.04.007_bib80","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ane.12799","article-title":"Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies","volume":"137","author":"Falip","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jaut.2019.04.007_bib81","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00415-015-8002-2","article-title":"Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings","volume":"263","author":"Baysal-Kirac","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib82","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1212\/NXI.0000000000000122","article-title":"ILAE type 3 hippocampal sclerosis in patients with anti-GAD-related epilepsy","volume":"2","author":"Glover","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jaut.2019.04.007_bib83","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/epi.12220","article-title":"International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods","volume":"54","author":"Bl\u00fcmcke","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaut.2019.04.007_bib84","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp.70.3.386","article-title":"Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia","volume":"70","author":"Takenoshita","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib85","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/jnnp.74.7.998","article-title":"Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus","volume":"74","author":"Antonini","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajo.2004.12.052","article-title":"Downbeating nystagmus and muscle spasms in a patient with glutamic-acid decarboxylase antibodies","volume":"140","author":"Ances","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2019.04.007_bib87","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainres.2006.03.064","article-title":"A rare saccade velocity profile in Stiff-Person Syndrome with cerebellar degeneration","volume":"1093","author":"Zivotofsky","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.jaut.2019.04.007_bib88","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/brain\/awh532","article-title":"Vertical nystagmus: clinical facts and hypotheses","volume":"128","author":"Pierrot-Deseilligny","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2018.01.013","article-title":"Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide","volume":"317","author":"Baizabal-Carvallo","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib90","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archneur.62.8.1300","article-title":"Anti-GAD antibodies and periodic alternating nystagmus","volume":"62","author":"Tilikete","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib91","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/01.wnl.0000183068.42803.33","article-title":"Eye movement abnormalities in stiff person syndrome","volume":"65","author":"Economides","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib92","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/01658107.2015.1011755","article-title":"Alternating skew deviation in association with anti-glutamic acid decarboxylase antibodies","volume":"39","author":"Farooq","year":"2015","journal-title":"Neuro Ophthalmol."},{"key":"10.1016\/j.jaut.2019.04.007_bib93","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/01.wnl.0000319725.22925.b4","article-title":"Stiff eyes in stiff-person syndrome","volume":"71","author":"Oskarsson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib94","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/mds.25239","article-title":"Supranuclear gaze palsy in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus","volume":"27","author":"Peeters","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib95","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.clineuro.2012.11.008","article-title":"Miller Fisher syndrome with positivity of anti-GAD antibodies","volume":"115","author":"Pietrini","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jaut.2019.04.007_bib96","first-page":"3431849","article-title":"Miller-Fisher syndrome: are anti-GAD antibodies implicated in its pathophysiology?","volume":"2016","author":"Dagklis","year":"2016","journal-title":"Case Rep. Neurol. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib97","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/WCO.0b013e32835c5e1d","article-title":"Saccadic intrusions: review and update","volume":"26","author":"Lemos","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib98","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clineuro.2008.03.005","article-title":"Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase","volume":"110","author":"Markakis","year":"2008","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jaut.2019.04.007_bib99","doi-asserted-by":"crossref","first-page":"545490","DOI":"10.1155\/2014\/545490","article-title":"Dancing eye syndrome\" secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer","volume":"2014","author":"Laroumagne","year":"2014","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib100","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00415-011-6377-2","article-title":"Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations","volume":"259","author":"Iizuka","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib101","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/jnnp.2004.036558","article-title":"Stiff person syndrome with eye movement abnormality, myasthenia gravis, and thymoma","volume":"76","author":"Thomas","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib102","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/mds.21374","article-title":"GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma","volume":"22","author":"McHugh","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-510X(01)00602-5","article-title":"Stiff-person syndrome associated with invasive thymoma: a case report","volume":"193","author":"Hagiwara","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib104","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2015.2378","article-title":"Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults","volume":"72","author":"Jones","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJM199302253280805","article-title":"Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer","volume":"328","author":"Folli","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib106","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib107","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jns.2013.12.015","article-title":"Evidence of T-cell mediated neuronal injury in stiff-person syndrome with anti-amphiphysin antibodies","volume":"337","author":"Poh","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0896-6273(00)81165-4","article-title":"Autoimmunity to gephyrin in stiff-man syndrome","volume":"26","author":"Butler","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2019.04.007_bib109","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ana.410360419","article-title":"Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy","volume":"36","author":"Nemni","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib110","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10072-014-2058-0","article-title":"Anti-GAD antibody-positive myoclonic leg jerks","volume":"36","author":"Velardo","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib111","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1212\/WNL.0b013e3182a8254f","article-title":"Orthostatic tremor heralding the onset of stiff-person syndrome","volume":"81","author":"Vetrugno","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib112","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(96)00065-2","article-title":"Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia","volume":"143","author":"Giometto","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib113","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2169\/internalmedicine.40.968","article-title":"Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer","volume":"40","author":"Kono","year":"2001","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/jnnp.2006.089268","article-title":"Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies","volume":"78","author":"Vulliemoz","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib115","doi-asserted-by":"crossref","first-page":"804","DOI":"10.5692\/clinicalneurol.cn-000740","article-title":"Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies","volume":"55","author":"Akaishi","year":"2015","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jaut.2019.04.007_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121364","article-title":"Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity","volume":"10","author":"Gresa-Arribas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.04.007_bib117","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.autrev.2009.05.003","article-title":"Structural biology of the GAD autoantigen","volume":"9","author":"Fenalti","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2019.04.007_bib118","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-D","article-title":"Two genes encode distinct glutamate decarboxylases","volume":"7","author":"Erlander","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2019.04.007_bib119","doi-asserted-by":"crossref","first-page":"280e6","DOI":"10.1038\/nsmb1228","article-title":"GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop","volume":"14","author":"Fenalti","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jaut.2019.04.007_bib120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molimm.2009.08.022","article-title":"Structural determinants of GAD antigenicity","volume":"47","author":"Arafat","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib121","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.4049\/jimmunol.175.11.7755","article-title":"Analysis of GAD65 autoantibodies in stiff-person syndrome patients","volume":"175","author":"Raju","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib122","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.178.6.2097","article-title":"Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome","volume":"178","author":"Butler","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018411","article-title":"An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes","volume":"6","author":"Jayakrishnan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.04.007_bib124","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1073\/pnas.90.7.2832","article-title":"Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase","volume":"90","author":"Richter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.04.007_bib125","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4049\/jimmunol.156.2.818","article-title":"Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition","volume":"156","author":"Daw","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib126","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1468-1331.2004.00933.x","article-title":"Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies","volume":"12","author":"Vianello","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib127","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2337\/diabetes.52.11.2689","article-title":"Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs","volume":"52","author":"Padoa","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2019.04.007_bib128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/cei.12026","article-title":"Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals","volume":"171","author":"Ch\u00e9ramy","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib129","first-page":"78","article-title":"Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions","volume":"9","author":"Manto","year":"2015","journal-title":"Front. Behav."},{"key":"10.1016\/j.jaut.2019.04.007_bib130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.180.2.595","article-title":"Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus","volume":"180","author":"Kim","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib131","article-title":"Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8\/8-positive Type 1 diabetes mellitus","author":"Hampe","year":"2018","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib132","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410440209","article-title":"Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome","volume":"44","author":"Dinkel","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib133","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/08916930701619565","article-title":"Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies","volume":"41","author":"Vianello","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2019.04.007_bib134","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fncel.2016.00130","article-title":"Anti-GAD65 containing cerebrospinal fluid does not alter GABAergic transmission","volume":"10","author":"Hackert","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jaut.2019.04.007_bib135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fneur.2015.00189","article-title":"Serum from a patient with GAD65 antibody-associated limbic encephalitis did not alter GABAergic neurotransmission in cultured hippocampal networks","volume":"6","author":"Stemmler","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib136","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/cercor\/bht060","article-title":"The GABAergic septohippocampal pathway is directly involved in internal processes related to operant reward learning","volume":"24","author":"Vega-Flores","year":"2014","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.jaut.2019.04.007_bib137","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jamaneurol.2013.3499","article-title":"Neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome","volume":"70","author":"Chang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib138","first-page":"1550","article-title":"Association of HLA-DQB1*0201 with stiff-man syndrome","volume":"77","author":"Pugliese","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2019.04.007_bib139","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1212\/NXI.0000000000000416","article-title":"Multiplex family with GAD65-Abs neurologic syndromes","volume":"5","author":"Belbezier","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jaut.2019.04.007_bib140","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.clinph.2015.03.010","article-title":"Familial case reports of stiff-person syndrome","volume":"126","author":"Xiao","year":"2015","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jaut.2019.04.007_bib141","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.WNL.0000092016.98256.21","article-title":"Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter","volume":"61","author":"Burns","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib142","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.expneurol.2006.06.012","article-title":"Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab)","volume":"202","author":"Vianello","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib143","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13023-018-0787-5","article-title":"GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies","volume":"13","author":"Liimatainen","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2019.04.007_bib144","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2015.03.009","article-title":"GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders","volume":"281","author":"Fouka","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib145","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/brain\/awl245","article-title":"Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome","volume":"129","author":"Raju","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib146","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/jaut.1999.0280","article-title":"GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient","volume":"12","author":"Schloot","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.04.007_bib147","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(00)02431-4","article-title":"Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus","volume":"356","author":"Lohmann","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.04.007_bib148","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2008.10.002","article-title":"Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome","volume":"32","author":"Skorstad","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.04.007_bib149","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dmrr.1083","article-title":"Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes","volume":"26","author":"H\u00e4nninen","year":"2010","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"10.1016\/j.jaut.2019.04.007_bib150","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1073\/pnas.071050898","article-title":"Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase","volume":"98","author":"Hiemstra","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.04.007_bib151","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.61.6.938","article-title":"Stiff-person syndrome following West Nile fever","volume":"61","author":"Hassin-Baer","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib152","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.21123","article-title":"Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases","volume":"61","author":"Manto","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib153","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-6-3","article-title":"Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia","volume":"6","author":"Manto","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2019.04.007_bib154","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.expneurol.2012.10.013","article-title":"Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats","volume":"239","author":"Hansen","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib155","article-title":"Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.04.007_bib156","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1750-1172-8-82","article-title":"Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats","volume":"8","author":"Hampe","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2019.04.007_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016775","article-title":"Human stiff-person syndrome IgG induces anxious behavior in rats","volume":"6","author":"Geis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.04.007_bib158","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.expneurol.2013.02.010","article-title":"Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome","volume":"247","author":"Dalakas","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib159","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(05)66376-3","article-title":"Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin","volume":"365","author":"Sommer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.04.007_bib160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00702-012-0773-3","article-title":"Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer","volume":"119","author":"Geis","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jaut.2019.04.007_bib161","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/brain\/awq253","article-title":"Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition","volume":"133","author":"Geis","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib162","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/brain\/awv324","article-title":"Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition","volume":"139","author":"Werner","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib163","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO;2-0","article-title":"Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase","volume":"46","author":"Ishida","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib164","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-510X(00)00272-0","article-title":"Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase","volume":"175","author":"Mitoma","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp.47.3.280","article-title":"The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine","volume":"47","author":"Meinck","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib166","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.51.1.85","article-title":"Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome","volume":"51","author":"Floeter","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib167","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1212\/WNL.59.3.449","article-title":"Increased brainstem excitability in stiff-person syndrome","volume":"59","author":"Molloy","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib168","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/jnnp.2003.018135","article-title":"Hyperekplexia and stiff-man syndrome: abnormal brainstem reflexes suggest a physiological relationship","volume":"75","author":"Khasani","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib169","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/brain\/123.11.2231","article-title":"Motor cortex excitability in stiff-person syndrome","volume":"123","author":"Sandbrink","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.007_bib170","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/01.WNL.0000120543.65812.33","article-title":"Stiff-person syndromes: motor cortex hyperexcitability correlates with anti-GAD autoimmunity","volume":"62","author":"Koerner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib171","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archneur.62.6.970","article-title":"Brain gamma-aminobutyric acid changes in stiff-person syndrome","volume":"62","author":"Levy","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib172","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1528-1167.2010.02644.x","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels","volume":"51","author":"Stagg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaut.2019.04.007_bib173","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1212\/WNL.49.4.1026","article-title":"Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity","volume":"49","author":"Saiz","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib174","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jns.2016.11.066","article-title":"Stiff person syndrome masquerading as multiple sclerosis","volume":"372","author":"Sabatino","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib175","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome","volume":"345","author":"Dalakas","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib176","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2169\/internalmedicine.48.1802","article-title":"Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia","volume":"48","author":"Nanri","year":"2009","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib177","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1590\/S0004-282X2011000700030","article-title":"Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy","volume":"69","author":"Pedroso","year":"2011","journal-title":"Arq Neuropsiquiatr."},{"key":"10.1016\/j.jaut.2019.04.007_bib178","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12311-013-0534-3","article-title":"Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies","volume":"13","author":"Planche","year":"2014","journal-title":"Cerebellum"},{"key":"10.1016\/j.jaut.2019.04.007_bib179","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ana.25002","article-title":"A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome","volume":"82","author":"Dalakas","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000339446","article-title":"Childhood stiff-person syndrome improved with rituximab","volume":"4","author":"Fekete","year":"2012","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib181","first-page":"e1387","article-title":"Evaluation of treatment outcomes in patients with stiff person syndrome with rituximab vs. Standard of care","volume":"9","author":"Rineer","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2019.04.007_bib182","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.2169\/internalmedicine.1043-18","article-title":"Stiff-person syndrome with waldenstr\u00f6m macroglobulinemia","volume":"57","author":"Horiuchi","year":"2018","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2019.04.007_bib183","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13317-017-0100-y","article-title":"Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment","volume":"8","author":"Du","year":"2017","journal-title":"Auto Immune Highlights"},{"key":"10.1016\/j.jaut.2019.04.007_bib184","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.25167","article-title":"Treatment of stiff-person syndrome with chronic plasmapheresis","volume":"28","author":"De la Casa-Fages","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.transci.2008.09.005","article-title":"Plasma exchange for anti-GAD associated non paraneoplastic limbic encephalitis","volume":"39","author":"Mazzi","year":"2008","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib186","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2008.05.015","article-title":"Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies","volume":"199","author":"Mat\u00e0","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib187","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1474-4422(03)00534-9","article-title":"Excellent response to steroid treatment in anti-GAD cerebellar ataxia","volume":"2","author":"Lauria","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib188","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/mds.21041","article-title":"Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy","volume":"21","author":"Kim","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jaut.2019.04.007_bib189","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/01.wnl.0000238389.83574.be","article-title":"Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia","volume":"67","author":"McFarland","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.007_bib190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/jnnp.2007.142745","article-title":"Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies","volume":"80","author":"Virgilio","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.007_bib191","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","article-title":"Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies","volume":"30","author":"Malter","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.jaut.2019.04.007_bib192","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","article-title":"Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy","volume":"80","author":"Daif","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jaut.2019.04.007_bib193","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.12.010","article-title":"Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies","volume":"129","author":"Carre\u00f1o","year":"2017","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jaut.2019.04.007_bib194","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2009.09.004","article-title":"Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?","volume":"287","author":"Blanc","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.007_bib195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fneur.2015.00167","article-title":"Treating a GAD65 antibody-associated limbic encephalitis with basiliximab: a case study","volume":"6","author":"Widman","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib196","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/intimm\/dxx037","article-title":"Efficiency of antibody therapy in demyelinating diseases","volume":"29","author":"Akaishi","year":"2017","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2019.04.007_bib197","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/jamaneurol.2014.1297","article-title":"Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program","volume":"71","author":"Sanders","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib198","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1469-8749.2008.03217.x","article-title":"Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency","volume":"51","author":"Akman","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jaut.2019.04.007_bib199","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1528-1167.2007.01500.x","article-title":"Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus","volume":"49","author":"Kanter","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaut.2019.04.007_bib200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jns.2014.05.032","article-title":"Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase","volume":"343","author":"Markakis","year":"2014","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119301222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119301222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:23:15Z","timestamp":1760257395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119301222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":200,"alternative-id":["S0896841119301222"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.04.007","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neurological syndromes associated with glutamic acid decarboxylase antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}